Argatroban Therapy in Heparin-Induced Thrombocytopenia With Hepatic Dysfunction
- 31 May 2006
- Vol. 129 (5), 1167-1175
- https://doi.org/10.1378/chest.129.5.1167
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- When Heparins Promote ThrombosisCirculation, 2005
- Heparin-Induced Thrombocytopenia: Recognition, Treatment, and PreventionChest, 2004
- Risk of thrombosis in patients with malignancy and heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 2004
- Treatment of Heparin-Induced ThrombocytopeniaArchives of Internal Medicine, 2004
- Argatroban for Heparin-Induced Thrombocytopenia in Hepato-Renal Failure and CVVHDAnnals of Pharmacotherapy, 2003
- Argatroban Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaArchives of Internal Medicine, 2003
- Argatroban Dosing in Patients with Heparin-Induced ThrombocytopeniaAnnals of Pharmacotherapy, 2003
- Argatroban Anticoagulant Therapy in Patients With Heparin-Induced ThrombocytopeniaCirculation, 2001
- Impact of the patient population on the risk for heparin-induced thrombocytopeniaBlood, 2000
- The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal DysfunctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000